Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-01 11:05 am Sale |
2024-09-30 | 13G | CVRx, Inc. CVRX |
JOHNSON & JOHNSON JNJ |
4,103,430 17.000% |
-5,906 (-0.14%) |
Filing History |
| 2024-10-18 5:23 pm Purchase |
2024-09-30 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
JOHNSON & JOHNSON JNJ |
2,498,051 6.800% |
2,498,051 (New Position) |
Filing History |
| 2024-10-18 4:47 pm Unchanged |
2024-09-30 | 13G | MeiraGTx Holdings plc MGTX |
JOHNSON & JOHNSON JNJ |
6,641,064 8.600% |
0 (Unchanged) |
Filing History |
| 2024-07-30 9:06 pm Purchase |
2024-04-10 | 13G | Rallybio Corporation RLYB |
JOHNSON & JOHNSON JNJ |
3,636,363 8.800% |
3,636,363 (New Position) |
Filing History |
| 2024-05-20 5:17 pm Sale |
2024-05-17 | 13G | Kenvue Inc. KVUE |
JOHNSON & JOHNSON JNJ |
0 0.000% |
-182,329,550 (Position Closed) |
Filing History |
| 2024-04-10 5:12 pm Purchase |
2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM |
JOHNSON & JOHNSON JNJ |
1,979,173 10.700% |
1,979,173 (New Position) |
Filing History |
| 2024-02-13 5:07 pm Sale |
2023-12-29 | 13G | Johnson & Johnson JNJ |
The Vanguard Group | 229,372,559 9.530% |
-17,454,062 (-7.07%) |
Filing History |
| 2024-02-02 5:07 pm Sale |
2023-12-31 | 13G | BiomX Inc. PHGE |
JOHNSON & JOHNSON JNJ |
211,340 4.600% |
-2,000 (-0.94%) |
Filing History |
| 2024-02-02 4:52 pm Sale |
2023-12-31 | 13G | CVRx, Inc. CVRX |
JOHNSON & JOHNSON JNJ |
4,109,336 19.200% |
-237 (-0.01%) |
Filing History |
| 2024-02-02 4:32 pm Purchase |
2023-12-31 | 13G | Nanobiotix S.A. NBTX |
JOHNSON & JOHNSON JNJ |
5,623,816 11.900% |
5,623,816 (New Position) |
Filing History |
| 2024-01-30 12:46 pm Sale |
2023-12-31 | 13G | Johnson & Johnson JNJ |
STATE STREET CORP STT |
132,996,283 5.520% |
-9,451,661 (-6.64%) |
Filing History |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | Johnson & Johnson JNJ |
BLACKROCK INC BLK |
186,308,341 7.700% |
-12,494,428 (-6.28%) |
Filing History |
| 2024-01-24 12:51 pm Purchase |
2023-12-31 | 13G | Kenvue Inc. KVUE |
JOHNSON & JOHNSON JNJ |
182,329,550 9.500% |
182,329,550 (New Position) |
Filing History |
| 2023-02-10 07:53 am Sale |
2022-12-31 | 13G | Johnson & Johnson JNJ |
STATE STREET CORP STT |
142,447,944 5.450% |
-2,548,183 (-1.76%) |
Filing History |
| 2023-02-09 11:25 am Purchase |
2022-12-30 | 13G | Johnson & Johnson JNJ |
The Vanguard Group | 246,826,621 9.440% |
12,043,989 (+5.13%) |
Filing History |
| 2023-01-31 1:58 pm Sale |
2022-12-31 | 13G | Johnson & Johnson JNJ |
BLACKROCK INC BLK |
198,802,769 7.600% |
-1,218,583 (-0.61%) |
Filing History |
| 2023-01-27 11:12 am Sale |
2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
JOHNSON & JOHNSON JNJ |
3,670,516 8.200% |
-89,118 (-2.37%) |
Filing History |
| 2023-01-11 1:00 pm Unchanged |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
JOHNSON & JOHNSON JNJ |
2,449,183 4.980% |
0 (Unchanged) |
Filing History |
| 2022-11-14 2:40 pm Purchase |
2022-11-09 | 13G | MeiraGTx Holdings plc MGTX |
JOHNSON & JOHNSON JNJ |
6,641,064 13.700% |
3,742,514 (+129.12%) |
Filing History |
| 2022-02-14 12:37 pm Purchase |
2021-12-31 | 13G | Johnson & Johnson JNJ |
STATE STREET CORP STT |
144,996,127 5.510% |
966,493 (+0.67%) |
Filing History |